/stocks — the workspaceLOADING
BeOne Medicines Ltd. (ONC) is a pharmaceutical preparations company. Piotroski F-Score 7/9. 34 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-05 from ONC's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
eight-variable model; a screen for earnings-quality review, not an accusation
A plain-English read on ONC plus an auto-SWOT — built from ONC's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ONC using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| PRIMECAP Management | $1.48B | 1.2% of portfolio |
| Lee Chan HenrySVP, General Counsel | SELL | $201K | view → |
| Wang LaiPresident, Global Head of R&D | SELL | $296K | view → |
| OYLER JOHNChief Executive Officer | SELL | $934K | view → |
| Wu XiaobinPresident and COO | SELL | $357K | view → |
| Wang LaiPresident, Global Head of R&D | SELL | $310K | view → |
| Lee Chan HenrySVP, General Counsel | SELL | $157K | view → |
| OYLER JOHNChief Executive Officer | SELL | $981K | view → |
| Wu XiaobinPresident and COO | SELL | $362K | view → |
Projected from ONC's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment ONC files its announcement.
ONC has rallied after 5 of its last 8 earnings reports.
Earnings reactions have been moderate.
ONC has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+11.4% and -10.0%).
A more typical earnings reaction has been approximately ±4.8%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-06 | +6.6% |
| 2026-04-14 | +4.7% |
| 2026-02-26 | -10.0% |
| 2025-11-06 | -0.4% |
| 2025-08-29 | +11.4% |
| 2025-08-06 | -2.9% |
| 2025-04-28 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +2.0% |
| 2025-02-27 | +4.9% |